{
    "clinical_study": {
        "@rank": "100849", 
        "arm_group": [
            {
                "arm_group_label": "Histologic grade", 
                "description": "According to the modified criteria of Bloom and Richardson grading system:  grade 1, 2 and 3"
            }, 
            {
                "arm_group_label": "Axillary metastasis", 
                "description": "Group A: axillary lymph node metastasis Group B: no axillary lymphatic metastasis"
            }, 
            {
                "arm_group_label": "Modified Nottingham prognostic index", 
                "description": "NPI = pathological tumour size (cm) \u00d7 0.2 + lymph node stage (1, 2 or 3) + histological grade (1, 2 or 3)\nThe cut-off points of the index were 3.4 and 5.4 to divide patients into the good (\u22643.4), moderate (3.41-5.4) and poor (>5.4) prognostic groups"
            }, 
            {
                "arm_group_label": "Oestrogen receptor status", 
                "description": "Negative Positive"
            }, 
            {
                "arm_group_label": "Progesterone receptor status", 
                "description": "Negative Positive"
            }, 
            {
                "arm_group_label": "HER-2 neu status", 
                "description": "Negative Positive"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine findings of positron emission tomography and\n      diffusion weighted magnetic resonance in primary lesion and axillary metastasis of breast\n      cancer and compare of two imaging modality in these patients."
        }, 
        "brief_title": "Assessment of Positron Emission Tomography and Diffusion Magnetic Resonance Findings in Breast Cancer", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "We aimed that to correlate both primary lesion 18F-fluorodeoxyglucose (FDG) maximum\n      standardized uptake value (SUVmax) and diffusion-weighted imaging (DWI) apparent diffusion\n      coefficient (ADC) with clinicopathological prognostic factors and compare the prognostic\n      value of these indexes in breast cancer in this study. The evaluated and compared parameters\n      are SUVmax and ADC according to age, tumour size, lymph node metastasis, receptor status,\n      histologic grade, modified Nottingham prognostic index."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Newly diagnosis of breast cancer for which surgical intervention is planned\n\n        Exclusion Criteria:\n\n          -  patients received neoadjuvant chemotherapy\n\n          -  before breast surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Female patients with breast cancer"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01942759", 
            "org_study_id": "BC-PET-MR-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast Neoplasms", 
            "Positron-Emission Tomography", 
            "Diffusion Magnetic Resonance Imaging"
        ], 
        "lastchanged_date": "September 11, 2013", 
        "location": {
            "contact": {
                "email": "ozenaynur@gmail.com", 
                "last_name": "Aynur Ozen, MD", 
                "phone": "00 90 212 440 40 00"
            }, 
            "facility": {
                "address": {
                    "city": "Istanbul", 
                    "country": "Turkey"
                }, 
                "name": "Bagcilar Training and Research Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "6", 
        "official_title": "Assessment of Positron Emission Tomography and Diffusion Magnetic Resonance Findings in Primary Lesion and Axillary Metastasis of Breast Cancer", 
        "overall_contact": {
            "email": "ozenaynur@gmail.com", 
            "last_name": "Aynur Ozen, MD", 
            "phone": "00 90 212 440 40 00"
        }, 
        "overall_official": {
            "affiliation": "Bagcilar Training & Research Hospital", 
            "last_name": "AYNUR OZEN, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To evaluate the relationships between both SUVmax and ADC and clinicopathological prognostic factors", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01942759"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bagcilar Training and Research Hospital", 
            "investigator_full_name": "Aynur Ozen", 
            "investigator_title": "Aynur Ozen", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Bagcilar Training and Research Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bagcilar Training and Research Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}